{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:08:33Z","timestamp":1791925713863,"version":"4.3.4"},"reference-count":176,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ejphar.2023.175726","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T23:38:33Z","timestamp":1681515513000},"page":"175726","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["The potential of CYP46A1 as a novel therapeutic target for neurological disorders: An updated review of mechanisms"],"prefix":"10.1016","volume":"949","author":[{"given":"Mohaddeseh Sadat","family":"Alavi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamreza","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein A.","family":"Ghanimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5032-4263","authenticated-orcid":false,"given":"Ali","family":"Roohbakhsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2023.175726_bib1","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1083\/jcb.200404149","article-title":"Neuronal membrane cholesterol loss enhances amyloid peptide generation","volume":"167","author":"Abad-Rodriguez","year":"2004","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejphar.2023.175726_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2020.105794","article-title":"Bile acid biosynthesis in Smith-Lemli-Opitz syndrome bypassing cholesterol: potential importance of pathway intermediates","volume":"206","author":"Abdel-Khalik","year":"2021","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ejphar.2023.175726_bib3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1194\/jlr.P071639","article-title":"Defective cholesterol metabolism in amyotrophic lateral sclerosis","volume":"58","author":"Abdel-Khalik","year":"2017","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejphar.2023.175726_bib4","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/00001756-200506210-00007","article-title":"24S-hydroxycholesterol induces inflammatory gene expression in primary human neural cells","volume":"16","author":"Alexandrov","year":"2005","journal-title":"Neuroreport"},{"key":"10.1016\/j.ejphar.2023.175726_bib5","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1093\/hmg\/ddn106","article-title":"Striatal and nigral pathology in a lentiviral rat model of Machado-Joseph disease","volume":"17","author":"Alves","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejphar.2023.175726_bib6","doi-asserted-by":"crossref","first-page":"11876","DOI":"10.1074\/jbc.M116.723577","article-title":"Mapping of the allosteric site in cholesterol hydroxylase CYP46A1 for efavirenz, a drug that stimulates enzyme activity","volume":"291","author":"Anderson","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2023.175726_bib7","article-title":"Dravet syndrome: an overview","volume":"11","author":"Anwar","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.ejphar.2023.175726_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.661462","article-title":"Pharmacologic inhibition of ADAM10 attenuates brain tissue loss, axonal injury and pro-inflammatory gene expression following traumatic brain injury in mice","volume":"9","author":"Appel","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejphar.2023.175726_bib9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/22768","article-title":"Munc13-1 is essential for fusion competence of glutamatergic synaptic vesicles","volume":"400","author":"Augustin","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2023.175726_bib10","article-title":"Amyloid beta increases ABCA1 and HMGCR protein expression, and cholesterol synthesis and accumulation in mice neurons and astrocytes","volume":"1867","author":"Azizidoost","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.ejphar.2023.175726_bib11","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/biof.1541","article-title":"Emerging roles for high-density lipoproteins in neurodegenerative disorders","volume":"45","author":"Bahrami","year":"2019","journal-title":"Biofactors"},{"key":"10.1016\/j.ejphar.2023.175726_bib12","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1399-5618.2005.00239.x","article-title":"Reductions in cholesterol and synaptic markers in association cortex in mood disorders","volume":"7","author":"Beasley","year":"2005","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.ejphar.2023.175726_bib13","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.neulet.2013.09.003","article-title":"Oxysterols and Parkinson's disease: evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease","volume":"555","author":"Bj\u00f6rkhem","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2023.175726_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0304-3940(01)02277-7","article-title":"On the turnover of brain cholesterol in patients with Alzheimer's disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells","volume":"314","author":"Bogdanovic","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2023.175726_bib15","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/brain\/awv384","article-title":"CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington's disease","volume":"139","author":"Boussicault","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.ejphar.2023.175726_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/jms.4827","article-title":"Liquid chromatography coupled to tandem mass spectrometry methods for the selective and sensitive determination of 24S-hydroxycholesterol, its sulfate, and\/or glucuronide conjugates in plasma","volume":"57","author":"Brousseau","year":"2022","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.ejphar.2023.175726_bib17","doi-asserted-by":"crossref","first-page":"34674","DOI":"10.1074\/jbc.M402324200","article-title":"Differential expression of cholesterol hydroxylases in Alzheimer's disease","volume":"279","author":"Brown","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2023.175726_bib18","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1073\/pnas.0913828107","article-title":"ACAT1 gene ablation increases 24(S)-hydroxycholesterol content in the brain and ameliorates amyloid pathology in mice with AD","volume":"107","author":"Bryleva","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2023.175726_bib19","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.1093\/hmg\/ddv268","article-title":"Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology","volume":"24","author":"Burlot","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejphar.2023.175726_bib20","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1089\/neu.2007.0444","article-title":"Cortical injury increases cholesterol 24S hydroxylase (Cyp46) levels in the rat brain","volume":"25","author":"Cartagena","year":"2008","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.ejphar.2023.175726_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2009.12.080","article-title":"24S-hydroxycholesterol effects on lipid metabolism genes are modeled in traumatic brain injury","volume":"1319","author":"Cartagena","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2023.175726_bib22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/jcp.25488","article-title":"Can cholesterol metabolism modulation affect brain function and behavior?","volume":"232","author":"Cartocci","year":"2017","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2023.175726_bib23","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/ejn.12911","article-title":"Inhibiting cholesterol degradation induces neuronal sclerosis and epileptic activity in mouse hippocampus","volume":"41","author":"Chali","year":"2015","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2023.175726_bib24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00001756-200401190-00019","article-title":"APOE promoter, ACE1 and CYP46 polymorphisms and beta-amyloid in Alzheimer's disease","volume":"15","author":"Chalmers","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.ejphar.2023.175726_bib25","article-title":"Lipid pathway alterations in Parkinson's disease primary visual cortex","volume":"6","author":"Cheng","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2023.175726_bib26","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s10571-017-0574-1","article-title":"Tau proteins and tauopathies in alzheimer's disease","volume":"38","author":"Chong","year":"2018","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2023.175726_bib27","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1124\/dmd.108.025759","article-title":"24-hydroxycholesterol sulfation by human cytosolic sulfotransferases: formation of monosulfates and disulfates, molecular modeling, sulfatase sensitivity, and inhibition of liver x receptor activation","volume":"37","author":"Cook","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejphar.2023.175726_bib28","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.tem.2016.03.018","article-title":"LXR regulation of brain cholesterol: from development to disease","volume":"27","author":"Courtney","year":"2016","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.ejphar.2023.175726_bib29","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1007\/s12035-020-02232-6","article-title":"Cholesterol metabolism in neurodegenerative diseases: molecular mechanisms and therapeutic targets","volume":"58","author":"Dai","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2023.175726_bib30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1471-4159.2010.06912.x","article-title":"Altered cholesterol homeostasis contributes to enhanced excitotoxicity in Huntington's disease","volume":"115","author":"del Toro","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2023.175726_bib31","doi-asserted-by":"crossref","first-page":"17177","DOI":"10.1073\/pnas.1112688108","article-title":"A small pool of vesicles maintains synaptic activity in vivo","volume":"108","author":"Denker","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2023.175726_bib32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0304-3940(02)00443-3","article-title":"Genetic variation in the cholesterol 24-hydroxylase (CYP46) gene and the risk of Alzheimer's disease","volume":"328","author":"Desai","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2023.175726_bib33","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1515\/BC.2009.035","article-title":"Central nervous system: cholesterol turnover, brain development and neurodegeneration","volume":"390","author":"Dietschy","year":"2009","journal-title":"Biol. Chem."},{"key":"10.1016\/j.ejphar.2023.175726_bib34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00041433-200104000-00003","article-title":"Cholesterol metabolism in the brain","volume":"12","author":"Dietschy","year":"2001","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.ejphar.2023.175726_bib35","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1194\/jlr.R400004-JLR200","article-title":"Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal","volume":"45","author":"Dietschy","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejphar.2023.175726_bib36","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1093\/brain\/awv166","article-title":"CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer's disease","volume":"138","author":"Djelti","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.ejphar.2023.175726_bib37","doi-asserted-by":"crossref","first-page":"9137","DOI":"10.1523\/JNEUROSCI.1388-20.2020","article-title":"Neutral lipid cacostasis contributes to disease pathogenesis in amyotrophic lateral sclerosis","volume":"40","author":"Dodge","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2023.175726_bib38","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/s41598-020-80378-y","article-title":"Sterol auto-oxidation adversely affects human motor neuron viability and is a neuropathological feature of amyotrophic lateral sclerosis","volume":"11","author":"Dodge","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2023.175726_bib39","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.neulet.2018.10.030","article-title":"Cholesterol level correlate with disability score in patients with relapsing-remitting form of multiple sclerosis","volume":"687","author":"\u010eurfinov\u00e1","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2023.175726_bib40","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1113\/JP270590","article-title":"Membrane lipid rafts and neurobiology: age-related changes in membrane lipids and loss of neuronal function","volume":"594","author":"Egawa","year":"2016","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2023.175726_bib41","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bbrc.2007.05.033","article-title":"Regulation of alpha- and beta-secretase activity by oxysterols: cerebrosterol stimulates processing of APP via the alpha-secretase pathway","volume":"359","author":"Famer","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2023.175726_bib42","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1073\/pnas.1620506114","article-title":"Loss of astrocyte cholesterol synthesis disrupts neuronal function and alters whole-body metabolism","volume":"114","author":"Ferris","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2023.175726_bib43","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/acel.12206","article-title":"Up-regulation of \u03b2-amyloidogenesis in neuron-like human cells by both 24- and 27-hydroxycholesterol: protective effect of N-acetyl-cysteine","volume":"13","author":"Gamba","year":"2014","journal-title":"Aging Cell"},{"key":"10.1016\/j.ejphar.2023.175726_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114050","article-title":"Perinatal exposure of rats to the HIV drug efavirenz affects medial prefrontal cortex cytoarchitecture","volume":"178","author":"Garcia","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.175726_bib45","doi-asserted-by":"crossref","first-page":"11368","DOI":"10.1523\/JNEUROSCI.3795-04.2004","article-title":"Different presynaptic roles of synapsins at excitatory and inhibitory synapses","volume":"24","author":"Gitler","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2023.175726_bib46","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.biochi.2018.04.026","article-title":"Plasma oxysterol profiling in children reveals 24-hydroxycholesterol as a potential marker for Autism Spectrum Disorders","volume":"153","author":"Grayaa","year":"2018","journal-title":"Biochimie"},{"key":"10.1016\/j.ejphar.2023.175726_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2021.105902","article-title":"Plasma oxysterols: altered level of plasma 24-hydroxycholesterol in patients with bipolar disorder","volume":"211","author":"Guidara","year":"2021","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ejphar.2023.175726_bib48","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1111\/epi.17367","article-title":"A phase 2, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of soticlestat as adjunctive therapy in pediatric patients with Dravet syndrome or Lennox-Gastaut syndrome (ELEKTRA)","volume":"63","author":"Hahn","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2023.175726_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2021.106646","article-title":"A phase 1b\/2a study of soticlestat as adjunctive therapy in participants with developmental and\/or epileptic encephalopathies","volume":"174","author":"Halford","year":"2021","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejphar.2023.175726_bib50","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1073\/pnas.0813349106","article-title":"Reduction of cholesterol synthesis in the mouse brain does not affect amyloid formation in Alzheimer's disease, but does extend lifespan","volume":"106","author":"Halford","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2023.175726_bib51","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejphar.2017.02.038","article-title":"Regulation of autophagy by some natural products as a potential therapeutic strategy for cardiovascular disorders","volume":"802","author":"Hashemzaei","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.175726_bib52","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1111\/epi.17062","article-title":"Soticlestat, a novel cholesterol 24-hydroxylase inhibitor, reduces seizures and premature death in Dravet syndrome mice","volume":"62","author":"Hawkins","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2023.175726_bib53","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s12031-012-9778-5","article-title":"An intronic CYP46A1 polymorphism is associated with Alzheimer disease in a Chinese Han population","volume":"47","author":"He","year":"2012","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.ejphar.2023.175726_bib54","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.nbd.2013.10.022","article-title":"Exacerbation of ischemic brain injury in hypercholesterolemic mice is associated with pronounced changes in peripheral and cerebral immune responses","volume":"62","author":"Herz","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2023.175726_bib55","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/mds.21290","article-title":"Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease","volume":"22","author":"Huang","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ejphar.2023.175726_bib56","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/mds.27609","article-title":"Brain cholesterol metabolism and Parkinson's disease","volume":"34","author":"Huang","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ejphar.2023.175726_bib57","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/mt.2009.175","article-title":"Adeno-associated virus gene therapy with cholesterol 24-hydroxylase reduces the amyloid pathology before or after the onset of amyloid plaques in mouse models of Alzheimer's disease","volume":"18","author":"Hudry","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejphar.2023.175726_bib58","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12944-019-0965-z","article-title":"Role of cholesterol and sphingolipids in brain development and neurological diseases","volume":"18","author":"Hussain","year":"2019","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.ejphar.2023.175726_bib59","first-page":"267","article-title":"Anticonvulsant and ameliorative effects of pioglitazone on cognitive deficits, inflammation and apoptosis in the hippocampus of rat pups exposed to febrile seizure","volume":"22","author":"Hussein","year":"2019","journal-title":"Iran J. Basic Med. Sci."},{"key":"10.1016\/j.ejphar.2023.175726_bib60","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.neulet.2004.06.011","article-title":"Lack of association of the cholesterol 24-hydroxylase (CYP46) intron 2 polymorphism with Alzheimer's disease","volume":"367","author":"Ingelsson","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2023.175726_bib61","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/glia.23050","article-title":"Frequency of nuclear mutant huntingtin inclusion formation in neurons and glia is cell-type-specific","volume":"65","author":"Jansen","year":"2017","journal-title":"Glia"},{"key":"10.1016\/j.ejphar.2023.175726_bib62","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neulet.2016.03.048","article-title":"The association between CYP46A1 rs4900442 polymorphism and the risk of Alzheimer's disease: a meta-analysis","volume":"620","author":"Jia","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2023.175726_bib63","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00439-004-1107-9","article-title":"Variants of CYP46A1 may interact with age and APOE to influence CSF Abeta42 levels in Alzheimer's disease","volume":"114","author":"Johansson","year":"2004","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ejphar.2023.175726_bib64","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1093\/brain\/awz174","article-title":"CYP46A1 gene therapy deciphers the role of brain cholesterol metabolism in Huntington's disease","volume":"142","author":"Kacher","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.ejphar.2023.175726_bib65","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrneurol.2011.132","article-title":"Cholesterol metabolism in Huntington disease","volume":"7","author":"Karasinska","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ejphar.2023.175726_bib66","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Kiernan","year":"2011","journal-title":"Lancet"},{"issue":"Pt 9","key":"10.1016\/j.ejphar.2023.175726_bib67","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1093\/brain\/121.9.1687","article-title":"Autosomal dominant cerebellar ataxia type I. MRI-based volumetry of posterior fossa structures and basal ganglia in spinocerebellar ataxia types 1, 2 and 3","volume":"121","author":"Klockgether","year":"1998","journal-title":"Brain"},{"key":"10.1016\/j.ejphar.2023.175726_bib68","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/sj.mp.4001109","article-title":"Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease","volume":"7","author":"K\u00f6lsch","year":"2002","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.ejphar.2023.175726_bib69","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1126\/science.7569905","article-title":"Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95","volume":"269","author":"Kornau","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2023.175726_bib70","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1073\/pnas.0600316103","article-title":"Brain cholesterol turnover required for geranylgeraniol production and learning in mice","volume":"103","author":"Kotti","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2023.175726_bib71","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/nan.12286","article-title":"Evidence for altered cholesterol metabolism in Huntington's disease post mortem brain tissue","volume":"42","author":"Kreilaus","year":"2016","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.ejphar.2023.175726_bib72","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1017\/S0007114515000732","article-title":"A high-cholesterol diet enriched with polyphenols from Oriental plums (Prunus salicina) improves cognitive function and lowers brain cholesterol levels and neurodegenerative-related protein expression in mice","volume":"113","author":"Kuo","year":"2015","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.ejphar.2023.175726_bib73","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1042\/EBC20170035","article-title":"Regulation of selective autophagy: the p62\/SQSTM1 paradigm","volume":"61","author":"Lamark","year":"2017","journal-title":"Essays Biochem."},{"key":"10.1016\/j.ejphar.2023.175726_bib74","series-title":"Sex-dependent Effects of CYP46A1 Overexpression on Cognitive Function during Aging","author":"Latorre-Leal","year":"2021"},{"key":"10.1016\/j.ejphar.2023.175726_bib75","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1038\/s41598-017-02638-8","article-title":"Expression profiles of cholesterol metabolism-related genes are altered during development of experimental autoimmune encephalomyelitis in the rat spinal cord","volume":"7","author":"Lavrnja","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2023.175726_bib76","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0304-3940(02)00887-X","article-title":"Changes in human plasma levels of the brain specific oxysterol 24S-hydroxycholesterol during progression of multiple sclerosis","volume":"331","author":"Leoni","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2023.175726_bib77","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1159\/000095723","article-title":"Intron 2 (T\/C) CYP46 polymorphism is associated with Alzheimer's disease in Chinese patients","volume":"22","author":"Li","year":"2006","journal-title":"Dement. Geriatr. Cogn. Disord"},{"key":"10.1016\/j.ejphar.2023.175726_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24061098","article-title":"Computational drug design applied to the study of metabotropic glutamate receptors","volume":"24","author":"Llinas Del Torrent","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2023.175726_bib79","series-title":"24S-Hydroxycholesterol and Cerebellar Degeneration: Insights from SCA2","author":"Locci","year":"2022"},{"key":"10.1016\/j.ejphar.2023.175726_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103088","article-title":"The role of cholesterol metabolism in multiple sclerosis: from molecular pathophysiology to radiological and clinical disease activity","volume":"21","author":"Lorincz","year":"2022","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.ejphar.2023.175726_bib81","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/0271678X20911910","article-title":"Serum 24S-hydroxycholesterol predicts long-term brain structural and functional outcomes after hypoxia-ischemia in neonatal mice","volume":"41","author":"Lu","year":"2021","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.ejphar.2023.175726_bib82","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/pr.2018.49","article-title":"Upregulation of cholesterol 24-hydroxylase following hypoxia-ischemia in neonatal mouse brain","volume":"83","author":"Lu","year":"2018","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ejphar.2023.175726_bib83","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.1073\/pnas.96.13.7238","article-title":"cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain","volume":"96","author":"Lund","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2023.175726_bib84","doi-asserted-by":"crossref","first-page":"22980","DOI":"10.1074\/jbc.M303415200","article-title":"Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover","volume":"278","author":"Lund","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2023.175726_bib85","doi-asserted-by":"crossref","first-page":"9799","DOI":"10.1073\/pnas.93.18.9799","article-title":"Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation","volume":"93","author":"L\u00fctjohann","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2023.175726_bib86","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1017\/S1041610205003108","article-title":"Polymorphisms of the cholesterol 24-hydroxylase (CYP46A1) gene and the risk of Alzheimer's disease in a Chinese population","volume":"18","author":"Ma","year":"2006","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.ejphar.2023.175726_bib87","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1161\/ATVBAHA.116.307023","article-title":"Central nervous system lipoproteins: ApoE and regulation of cholesterol metabolism","volume":"36","author":"Mahley","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2023.175726_bib88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068534","article-title":"Is it possible to improve memory function by upregulation of the cholesterol 24S-hydroxylase (CYP46A1) in the brain?","volume":"8","author":"Maioli","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2023.175726_bib89","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/14734220510007914","article-title":"The wide spectrum of spinocerebellar ataxias (SCAs)","volume":"4","author":"Manto","year":"2005","journal-title":"Cerebellum"},{"key":"10.1016\/j.ejphar.2023.175726_bib90","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1091\/mbc.e07-09-0897","article-title":"Cholesterol loss enhances TrkB signaling in hippocampal neurons aging in vitro","volume":"19","author":"Martin","year":"2008","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ejphar.2023.175726_bib91","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1074\/jbc.M113.532846","article-title":"Pharmacologic stimulation of cytochrome P450 46A1 and cerebral cholesterol turnover in mice","volume":"289","author":"Mast","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2023.175726_bib92","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187168","article-title":"Transcriptional and post-translational changes in the brain of mice deficient in cholesterol removal mediated by cytochrome P450 46A1 (CYP46A1)","volume":"12","author":"Mast","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2023.175726_bib93","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1124\/mol.112.080424","article-title":"In silico and intuitive predictions of CYP46A1 inhibition by marketed drugs with subsequent enzyme crystallization in complex with fluvoxamine","volume":"82","author":"Mast","year":"2012","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.175726_bib94","doi-asserted-by":"crossref","first-page":"14284","DOI":"10.1021\/bi035512f","article-title":"Broad substrate specificity of human cytochrome P450 46A1 which initiates cholesterol degradation in the brain","volume":"42","author":"Mast","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejphar.2023.175726_bib95","doi-asserted-by":"crossref","first-page":"9546","DOI":"10.1073\/pnas.0803717105","article-title":"Crystal structures of substrate-bound and substrate-free cytochrome P450 46A1, the principal cholesterol hydroxylase in the brain","volume":"105","author":"Mast","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2023.175726_bib96","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.bbrc.2014.01.153","article-title":"Oxysterols in the brain of the cholesterol 24-hydroxylase knockout mouse","volume":"446","author":"Meljon","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2023.175726_bib97","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/nrn2738","article-title":"TrkB signalling pathways in LTP and learning","volume":"10","author":"Minichiello","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2023.175726_bib98","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jns.2010.03.002","article-title":"Case-control study of risk of Parkinson's disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan","volume":"293","author":"Miyake","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ejphar.2023.175726_bib99","doi-asserted-by":"crossref","DOI":"10.1038\/srep30928","article-title":"Neuronal cholesterol metabolism increases dendritic outgrowth and synaptic markers via a concerted action of GGTase-I and Trk","volume":"6","author":"Moutinho","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2023.175726_bib100","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s12035-014-8828-0","article-title":"Cholesterol 24S-hydroxylase overexpression inhibits the liver X receptor (LXR) pathway by activating small guanosine triphosphate-binding proteins (sGTPases) in neuronal cells","volume":"51","author":"Moutinho","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2023.175726_bib101","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/j.bbalip.2016.09.011","article-title":"Cholesterol 24-hydroxylase: brain cholesterol metabolism and beyond","volume":"1861","author":"Moutinho","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2023.175726_bib102","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1523\/JNEUROSCI.0244-14.2015","article-title":"Altered sensory experience exacerbates stable dendritic spine and synapse loss in a mouse model of Huntington's disease","volume":"35","author":"Murmu","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2023.175726_bib103","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.plipres.2016.09.002","article-title":"Oxysterols: from cholesterol metabolites to key mediators","volume":"64","author":"Mutemberezi","year":"2016","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.ejphar.2023.175726_bib104","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.276","article-title":"Mechanisms of RNA-induced toxicity in CAG repeat disorders","volume":"4","author":"Nalavade","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2023.175726_bib105","doi-asserted-by":"crossref","DOI":"10.5812\/ircmj.35677","article-title":"High cholesterol diet increases expression of cholesterol 24-hydroxylase and BACE1 in rat hippocampi: implications for the effect of diet cholesterol on memory","volume":"18","author":"Nikasa","year":"2016","journal-title":"Iran. Red Crescent Med. J."},{"key":"10.1016\/j.ejphar.2023.175726_bib106","series-title":"AES 2019 Annual Meeting Abstract Database","article-title":"TAK-935 (OV935) exerts neuroprotective and disease-modifying effects in a murine model of epileptogenesis","author":"Nishi","year":"2019"},{"key":"10.1016\/j.ejphar.2023.175726_bib107","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-74036-6","article-title":"Soticlestat, a novel cholesterol 24-hydroxylase inhibitor shows a therapeutic potential for neural hyperexcitation in mice","volume":"10","author":"Nishi","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2023.175726_bib108","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1111\/epi.17232","article-title":"Anticonvulsive properties of soticlestat, a novel cholesterol 24-hydroxylase inhibitor","volume":"63","author":"Nishi","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2023.175726_bib109","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13104-020-05053-x","article-title":"The cholesterol 24-hydroxylase activates autophagy and decreases mutant huntingtin build-up in a neuroblastoma culture model of Huntington's disease","volume":"13","author":"N\u00f3brega","year":"2020","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.ejphar.2023.175726_bib110","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00401-019-02019-7","article-title":"Restoring brain cholesterol turnover improves autophagy and has therapeutic potential in mouse models of spinocerebellar ataxia","volume":"138","author":"N\u00f3brega","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ejphar.2023.175726_bib111","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.nbd.2010.07.014","article-title":"Cerebral cortex structure in prodromal Huntington disease","volume":"40","author":"Nopoulos","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2023.175726_bib112","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1074\/jbc.M505179200","article-title":"Studies on the transcriptional regulation of cholesterol 24-hydroxylase (CYP46A1): marked insensitivity toward different regulatory axes","volume":"281","author":"Ohyama","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2023.175726_bib113","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/292598","article-title":"Cholesterol: its regulation and role in central nervous system disorders","volume":"2012","author":"Orth","year":"2012","journal-title":"Cholesterol"},{"key":"10.1016\/j.ejphar.2023.175726_bib114","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archneur.60.1.29","article-title":"Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism","volume":"60","author":"Papassotiropoulos","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ejphar.2023.175726_bib115","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.pharep.2017.04.018","article-title":"Possible anti-depressant effect of efavirenz and pro-depressive-like effect of voriconazole in specified doses in various experimental models of depression in mice","volume":"69","author":"Patel","year":"2017","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejphar.2023.175726_bib116","doi-asserted-by":"crossref","first-page":"17290","DOI":"10.1523\/JNEUROSCI.2619-13.2013","article-title":"The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors","volume":"33","author":"Paul","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2023.175726_bib117","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1093\/brain\/awz130","article-title":"Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy","volume":"142","author":"Pauletti","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.ejphar.2023.175726_bib118","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s13311-019-00737-0","article-title":"CYP46A1 activation by efavirenz leads to behavioral improvement without significant changes in amyloid plaque load in the brain of 5XFAD mice","volume":"16","author":"Petrov","year":"2019","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ejphar.2023.175726_bib119","first-page":"P255","article-title":"Restoring neuronal cholesterol efficiently rescues ALS mouse model","volume":"30","author":"Pigeut","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ejphar.2023.175726_bib120","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.568641","article-title":"Effects of CYP46A1 inhibition on long-term-depression in hippocampal slices ex vivo and 24S-hydroxycholesterol levels in mice in vivo","volume":"13","author":"Popiolek","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ejphar.2023.175726_bib121","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1471-4159.2012.07893.x","article-title":"Cholesterol metabolism is associated with soluble amyloid precursor protein production in Alzheimer's disease","volume":"123","author":"Popp","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2023.175726_bib122","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/cne.21605","article-title":"Neuronal expression and subcellular localization of cholesterol 24-hydroxylase in the mouse brain","volume":"507","author":"Ramirez","year":"2008","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ejphar.2023.175726_bib123","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1750-1172-5-40","article-title":"Huntington's disease: a clinical review","volume":"5","author":"Roos","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ejphar.2023.175726_bib124","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1146\/annurev.biochem.78.072407.103859","article-title":"Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain","volume":"78","author":"Russell","year":"2009","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejphar.2023.175726_bib125","doi-asserted-by":"crossref","DOI":"10.3390\/metabo12060554","article-title":"Lipid metabolism is dysregulated in the motor cortex white matter in amyotrophic lateral sclerosis","volume":"12","author":"Sadler","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.ejphar.2023.175726_bib126","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3233\/JAD-2012-112090","article-title":"Brain pericytes ABCA1 expression mediates cholesterol efflux but not cellular amyloid-\u03b2 peptide accumulation","volume":"30","author":"Saint-Pol","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ejphar.2023.175726_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105835","article-title":"Cholesterol 24-hydroxylase is a novel pharmacological target for anti-ictogenic and disease modification effects in epilepsy","author":"Salamone","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2023.175726_bib128","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1055\/s-0040-1701694","article-title":"Changing landscape of Dravet syndrome management: an overview","volume":"51","author":"Samanta","year":"2020","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.ejphar.2023.175726_bib129","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.mcn.2018.05.002","article-title":"Functional organization of postsynaptic glutamate receptors","volume":"91","author":"Scheefhals","year":"2018","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2023.175726_bib130","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE commission for classification and terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2023.175726_bib131","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1176\/appi.neuropsych.18090201","article-title":"Ages at onset of anxiety and depressive disorders in Parkinson's disease","volume":"31","author":"Seritan","year":"2019","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.ejphar.2023.175726_bib132","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1194\/jlr.M900174-JLR200","article-title":"The antifungal drug voriconazole is an efficient inhibitor of brain cholesterol 24S-hydroxylase in vitro and in vivo","volume":"51","author":"Shafaati","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejphar.2023.175726_bib133","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neulet.2005.08.048","article-title":"Association studies of cholesterol metabolism genes (CH25H, ABCA1 and CH24H) in Alzheimer's disease","volume":"391","author":"Shibata","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2023.175726_bib134","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1172\/JCI0216390","article-title":"Cholesterol, lipid rafts, and disease","volume":"110","author":"Simons","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2023.175726_bib135","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00418-010-0718-6","article-title":"Brain injury induces cholesterol 24-hydroxylase (Cyp46) expression in glial cells in a time-dependent manner","volume":"134","author":"Smiljanic","year":"2010","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.ejphar.2023.175726_bib136","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/jnc.15228","article-title":"24S-hydroxycholesterol: cellular effects and variations in brain diseases","volume":"157","author":"Sodero","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2023.175726_bib137","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1471-4159.2010.07079.x","article-title":"Regulation of tyrosine kinase B activity by the Cyp46\/cholesterol loss pathway in mature hippocampal neurons: relevance for neuronal survival under stress and in aging","volume":"116","author":"Sodero","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2023.175726_bib138","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1038\/emboj.2012.31","article-title":"Cholesterol loss during glutamate-mediated excitotoxicity","volume":"31","author":"Sodero","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.ejphar.2023.175726_bib139","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.neurobiolaging.2010.06.001","article-title":"Cellular stress from excitatory neurotransmission contributes to cholesterol loss in hippocampal neurons aging in vitro","volume":"32","author":"Sodero","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ejphar.2023.175726_bib140","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.cell.2012.06.054","article-title":"Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses","volume":"151","author":"Spann","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2023.175726_bib141","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/jamaneurol.2020.0387","article-title":"Association of factors with elevated amyloid burden in clinically normal older individuals","volume":"77","author":"Sperling","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ejphar.2023.175726_bib142","doi-asserted-by":"crossref","first-page":"237","DOI":"10.14336\/AD.2015.1030","article-title":"Higher plasma LDL-cholesterol is associated with preserved executive and fine motor functions in Parkinson's disease","volume":"7","author":"Sterling","year":"2016","journal-title":"Aging Dis."},{"key":"10.1016\/j.ejphar.2023.175726_bib143","first-page":"3224","article-title":"Significant association of TREM-1 with HMGB1, TLRs and RAGE in the pathogenesis of insulin resistance in obese diabetic populations","volume":"9","author":"Subramanian","year":"2017","journal-title":"Am. J. Trans. Res."},{"key":"10.1016\/j.ejphar.2023.175726_bib144","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1152\/jn.00890.2015","article-title":"Endogenous 24S-hydroxycholesterol modulates NMDAR-mediated function in hippocampal slices","volume":"115","author":"Sun","year":"2016","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.ejphar.2023.175726_bib145","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/1073858414568122","article-title":"24(S)-Hydroxycholesterol as a modulator of neuronal signaling and survival","volume":"22","author":"Sun","year":"2016","journal-title":"Neuroscientist"},{"key":"10.1016\/j.ejphar.2023.175726_bib146","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.711734","article-title":"Brain-specific oxysterols and risk of schizophrenia in clinical high-risk subjects and patients with schizophrenia","volume":"12","author":"Sun","year":"2021","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.ejphar.2023.175726_bib147","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s004010050717","article-title":"Changes in weight and compositions of major membrane components of human brain during the span of adult human life of Swedes","volume":"94","author":"Svennerholm","year":"1997","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ejphar.2023.175726_bib148","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.642773","article-title":"Juvenile huntington's disease and other PolyQ diseases, update on neurodevelopmental character and comparative bioinformatic review of transcriptomic and proteomic data","volume":"9","author":"\u015awito\u0144ska-Kurkowska","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejphar.2023.175726_bib149","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.redox.2018.05.009","article-title":"A silver lining for 24-hydroxycholesterol in Alzheimer's disease: the involvement of the neuroprotective enzyme sirtuin 1","volume":"17","author":"Testa","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2023.175726_bib150","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.redox.2016.09.001","article-title":"Changes in brain oxysterols at different stages of Alzheimer's disease: their involvement in neuroinflammation","volume":"10","author":"Testa","year":"2016","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2023.175726_bib151","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0304-3940(03)00667-0","article-title":"Decreased levels of the brain specific 24S-hydroxycholesterol and cholesterol precursors in serum of multiple sclerosis patients","volume":"347","author":"Teunissen","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2023.175726_bib152","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/jnr.21266","article-title":"24S-hydroxycholesterol in relation to disease manifestations of acute experimental autoimmune encephalomyelitis","volume":"85","author":"Teunissen","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ejphar.2023.175726_bib153","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1074\/jbc.RA118.005639","article-title":"24(S),25-Epoxycholesterol and cholesterol 24S-hydroxylase (CYP46A1) overexpression promote midbrain dopaminergic neurogenesis in vivo","volume":"294","author":"Theofilopoulos","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2023.175726_bib154","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nchembio.1156","article-title":"Brain endogenous liver X receptor ligands selectively promote midbrain neurogenesis","volume":"9","author":"Theofilopoulos","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejphar.2023.175726_bib155","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1471-4159.2010.06661.x","article-title":"Increased expression of cholesterol 24S-hydroxylase results in disruption of glial glutamate transporter EAAT2 association with lipid rafts: a potential role in Alzheimer's disease","volume":"113","author":"Tian","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2023.175726_bib156","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1212\/01.WNL.0000144282.42222.DA","article-title":"Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups","volume":"63","author":"Tirschwell","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2023.175726_bib157","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000314333","article-title":"Effects of cholesterol and its 24S-OH and 25-OH oxysterols on choline acetyltransferase-positive neurons in brain slices","volume":"86","author":"Ullrich","year":"2010","journal-title":"Pharmacology"},{"key":"10.1016\/j.ejphar.2023.175726_bib158","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1096\/fj.13-231456","article-title":"Suppression of amyloid-\u03b2 production by 24S-hydroxycholesterol via inhibition of intracellular amyloid precursor protein trafficking","volume":"27","author":"Urano","year":"2013","journal-title":"Faseb. J."},{"key":"10.1016\/j.ejphar.2023.175726_bib159","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1517\/13543776.2014.989214","article-title":"Imidazo[1,2-a]pyridines as cholesterol 24-hydroxylase (CYP46A1) inhibitors: a patent evaluation (WO2014061676)","volume":"25","author":"Uto","year":"2015","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejphar.2023.175726_bib160","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1093\/hmg\/ddm170","article-title":"Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation","volume":"16","author":"Valenza","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejphar.2023.175726_bib161","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.nbd.2007.07.004","article-title":"Progressive dysfunction of the cholesterol biosynthesis pathway in the R6\/2 mouse model of Huntington's disease","volume":"28","author":"Valenza","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2023.175726_bib162","doi-asserted-by":"crossref","first-page":"9932","DOI":"10.1523\/JNEUROSCI.3355-05.2005","article-title":"Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease","volume":"25","author":"Valenza","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2023.175726_bib163","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1177\/1352458513499421","article-title":"Oxysterols and cholesterol precursors correlate to magnetic resonance imaging measures of neurodegeneration in multiple sclerosis","volume":"20","author":"van de Kraats","year":"2014","journal-title":"Mult. Scler."},{"key":"10.1016\/j.ejphar.2023.175726_bib164","first-page":"614","article-title":"Correlation of cholesterol 24-hydroxylase and ATP-binding cassette transporter A1 polymorphisms with Alzheimer's disease","volume":"87","author":"Wang","year":"2007","journal-title":"Zhonghua Yixue Zazhi"},{"key":"10.1016\/j.ejphar.2023.175726_bib165","article-title":"Regulation of Th17\/treg balance by 27-hydroxycholesterol and 24S-hydroxycholesterol correlates with learning and memory ability in mice","volume":"23","author":"Wang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2023.175726_bib166","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1161\/STROKEAHA.113.001326","article-title":"Cholesterol levels and risk of hemorrhagic stroke: a systematic review and meta-analysis","volume":"44","author":"Wang","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2023.175726_bib167","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1111\/febs.15727","article-title":"Cholesterol metabolism pathways - are the intermediates more important than the products?","volume":"288","author":"Wang","year":"2021","journal-title":"FEBS J."},{"key":"10.1016\/j.ejphar.2023.175726_bib168","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuropharm.2018.12.028","article-title":"Preferential enhancement of GluN2B-containing native NMDA receptors by the endogenous modulator 24S-hydroxycholesterol in hippocampal neurons","volume":"148","author":"Wei","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2023.175726_bib169","doi-asserted-by":"crossref","first-page":"24666","DOI":"10.1074\/jbc.M111.236273","article-title":"24(S)-hydroxycholesterol induces neuronal cell death through necroptosis, a form of programmed necrosis","volume":"286","author":"Yamanaka","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2023.175726_bib170","doi-asserted-by":"crossref","first-page":"27816","DOI":"10.1074\/jbc.M603781200","article-title":"Sterol intermediates from cholesterol biosynthetic pathway as liver X receptor ligands","volume":"281","author":"Yang","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2023.175726_bib171","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1007\/s11064-020-03114-y","article-title":"Kukoamine A protects against NMDA-induced neurotoxicity accompanied with down-regulation of GluN2B-containing NMDA receptors and phosphorylation of PI3K\/Akt\/GSK-3\u03b2 signaling pathway in cultured primary cortical neurons","volume":"45","author":"Yang","year":"2020","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejphar.2023.175726_bib172","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2021.113723","article-title":"Protective effect of Toll-like receptor 4 antagonist on inflammation, EEG, and memory changes following febrile seizure in Wistar rats","volume":"420","author":"Zaniani","year":"2022","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2023.175726_bib173","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2020.152381","article-title":"Glutamate affects cholesterol homeostasis within the brain via the up-regulation of CYP46A1 and ApoE","volume":"432","author":"Zhang","year":"2020","journal-title":"Toxicology"},{"key":"10.1016\/j.ejphar.2023.175726_bib174","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3389\/fncel.2014.00427","article-title":"The \u03b3-secretase complex: from structure to function","volume":"8","author":"Zhang","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2023.175726_bib175","doi-asserted-by":"crossref","first-page":"17181","DOI":"10.1073\/pnas.0800846105","article-title":"TrkB-mediated activation of geranylgeranyltransferase I promotes dendritic morphogenesis","volume":"105","author":"Zhou","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2023.175726_bib176","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923002376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923002376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T14:44:02Z","timestamp":1736347442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299923002376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":176,"alternative-id":["S0014299923002376"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.175726","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential of CYP46A1 as a novel therapeutic target for neurological disorders: An updated review of mechanisms","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.175726","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"175726"}}